Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
about
Toxic hepatitis in occupational exposure to solventsPrevalence and sonographic changes compatible with fatty liver disease in patients referred for abdominal ultrasound examination in Aracaju, SE.4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysisFasting time and lipid parameters: association with hepatic steatosis--data from a random population sample.3.0T ¹H magnetic resonance spectroscopy for assessment of steatosis in patients with chronic hepatitis C.Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification.Hepatic Artery and Portal Vein Doppler Indexes in Non-alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs.Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.In vivo characterization of the liver fat ¹H MR spectrum.Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.Association between the PNPLA3 I148M polymorphism and non-alcoholic fatty liver disease in the Uygur and Han ethnic groups of northwestern China.The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study.Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGES-Reykjavik study.Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease.Non-alcoholic fatty liver disease: The diagnosis and management.Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 yearsCoffee consumption and NAFLD: a community based study on 1223 subjects.Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.Genetic Variants in the SAMM50 Gene Create Susceptibility to Nonalcoholic Fatty Liver Disease in a Chinese Han PopulationNoninvasive diagnosis of pediatric nonalcoholic fatty liver diseaseHepatic fat and abdominal adiposity in early pregnancy together predict impaired glucose homeostasis in mid-pregnancy.Synergistic effect of fatty liver and smoking on metabolic syndromeQuantification of liver fat with magnetic resonance imaging.Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment.Pediatric nonalcoholic fatty liver disease.Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Shear wave elastography for liver stiffness measurement in clinical sonographic examinations: evaluation of intraobserver reproducibility, technical failure, and unreliable stiffness measurements.Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Non-alcoholic fatty liver disease in 2016.Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test.Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study.Assessment of Portal Venous and Hepatic Artery Haemodynamic Variation in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients.Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome.Clinical characteristics associated with hepatic steatosis on ultrasonography in patients with elevated alanine aminotransferase.Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis.Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study.Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease.A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.
P2860
Q22305492-9D0DF8EF-401C-41A9-879C-2E5CB5B0FCFAQ30390099-E94E6052-180D-40E4-9E96-B6D30CACF181Q30412771-7D4EEAC5-A963-4F08-8F08-15300D39C684Q30497534-B3A064B3-411B-48F0-917B-BCE15083DB24Q30738910-4B0947AE-9306-41BC-9862-27E579EFB208Q30971762-E6DD98D9-2CA8-4626-AD90-88A8C1ED2706Q33409801-907282FC-B678-4A5B-969C-621CF86B928FQ33474978-93AE1DC9-E5E6-45E6-A2CD-8FC2E59D6825Q33600668-707DA14D-FC08-4549-87E4-82BB991ACB78Q33735249-FD7B7197-44F4-4480-A4B0-7358392D0E50Q33990557-7960A043-18EE-4786-85B2-ACBCEBA8D9EFQ34021973-84E023DB-03EE-4827-88DB-7BF1BE670102Q34301321-3B25CFAD-4570-4422-886D-D8CB8FAEC4BAQ34303169-1134F292-6AC7-4B04-8D1C-AD2298A85BF6Q34844992-B2F879CA-A5D4-464E-810F-BFFA1F012B83Q35122446-65002F85-B64F-4850-A2DB-57E49E0B23A6Q35543956-32F1F394-55B5-40F6-8F5E-9A1B7D0C90F1Q35746991-9A76B21D-590A-4F01-B708-A66317FF0EF3Q35831047-6B9CC645-AC0D-45FF-AA13-067C088A36D6Q36118818-EB7AFCFD-E088-4C69-B8F0-2A3D5B60842AQ36279133-5C005831-6648-49A7-8BC7-780B8A60AC17Q36660316-244F075E-C412-4991-A86E-83F9EFE478FDQ37306682-02416FB0-DE3C-4B1D-9541-4DBB3EF2109AQ37420044-2B2FB722-376D-43B7-806E-E1E5C3B3E313Q37811338-A3EDDF88-3A20-4A5D-A3ED-54699E7DE6BFQ37873715-9EE81B88-06DE-4A42-8386-09826FDA3352Q38126776-8663A6A4-7591-4648-BB0B-2695E60372CEQ38128548-F102E1D5-4EE2-4CD4-B810-E6AF0089A987Q38190931-D34CFBE0-5FE0-4252-8830-8184805E1B3CQ38204970-6D76300A-1EB2-4601-8138-4786F308267AQ38932554-92AE955B-8750-4AF5-B929-47D77EC5E167Q40080468-13DF99A0-F8F7-4142-A130-D45226463FDFQ40502657-EC64CD86-F947-4568-8166-77D1BDABE99AQ41126354-06774CD6-2F63-42C1-80DD-618887655C84Q41697003-6E08D6D2-CEA2-44E9-97AC-F98CFD5CC268Q42751607-3F972C45-7654-4A96-9233-2091BB820C89Q44931170-94598A71-23F9-412C-8C14-B5B90CAFE673Q44977667-99C8074C-67EC-4253-8904-4317F0A95650Q45974435-C0514953-136D-47B6-9419-0DBAE0A2517AQ46177222-85C4B573-9A8B-4469-975F-69E5198931BD
P2860
Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
@en
type
label
Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
@en
prefLabel
Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
@en
P1476
Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
@en
P2093
Keith D Lindor
Phunchai Charatcharoenwitthaya
P304
37-54, viii
P356
10.1016/J.CLD.2007.02.014
P577
2007-02-01T00:00:00Z